Low-density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis.
Chemically or enzymatically modified low-density lipoproteins (LDL), with and without changes in surface charge, were studied in vivo in the healing, balloon catheter-deendothelialized rabbit aorta to determine the effect of LDL modification on its accumulation in arterial lesions. In this model, in which healing (reendothelialization) proceeds radially outward from individual aortic branch arteries, it was previously shown by autoradiography that two kinetically distinct compartments accumulated 125I-labeled LDL. In aortic regions which were still deendothelialized, accumulation was diffuse and labile. In contrast, at the edges of the islands of regenerating endothelium, LDL accumulation was intensely focal, as it is in human atherosclerotic lesions, and persisted for at least 40 h after injection in spite of falling levels of radiolabeled LDL in plasma [Chang, M. Y., et al. (1992) Arterioscler. Thromb. 12, 1088-1098]. In the present study, modified LDLs with gradations in charge change were prepared to clarify the role of changes in surface charge on focal aortic LDL accumulation. Oxidized LDL (weakly anionized), desialated LDL (weakly cationized), and reductively methylated LDL (no change in net charge) all accumulated focally. Focal accumulation of native LDL also occurred in ballooned rabbits fed probucol to inhibit LDL oxidation. Strongly anionized succinylated and diazobenzenearsonylated LDL and strongly cationized dimethylpropanediamine LDL did not accumulate focally. The results support the concept that focal sequestration of LDL in arterial lesions is mediated by specific, oxidation-independent patterns of charge and polarity on LDL which are disrupted by major changes in LDL surface charge.
Chang
M Y
MY
Boston Heart Foundation, Cambridge, Massachusetts 02142.
Lees
A M
AM
Lees
R S
RS
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001012:Aorta, Abdominal / Q000378:metabolism*; D001161:Arteriosclerosis / Q000378:metabolism*; D001345:Autoradiography; D003300:Copper / Q000494:pharmacology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000503:physiopathology; D004800:Enzymes, Immobilized / Q000494:pharmacology; D006801:Humans; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D009439:Neuraminidase / Q000494:pharmacology; D011817:Rabbits; D013387:Succinic Anhydrides / Q000378:metabolism; D010132:p-Azobenzenearsonate
D000814:Aniline Compounds; D004800:Enzymes, Immobilized; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL; D013387:Succinic Anhydrides; C031801:succinic anhydride; C050795:N,N-dimethyl-4-anisidine; D010132:p-Azobenzenearsonate; D003300:Copper; D009439:Neuraminidase